One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease—a KDIGO commentary
From MC1R to MC5R, a new horizon for the podoprotective effect of melanocortin
Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?
Kidney organoids: a 3-dimensional tool to unmask permeability factors in primary and recurrent FSGS
Progress, challenges, and pragmatic concessions in predicting relative risk of kidney survival in ARPKD
Clinical utility of donor-derived cell-free DNA testing for kidney transplant monitoring in selected patients
Using donor-derived cell-free DNA in kidney transplant patients: this jury needs more evidence
Simply measuring what matters—toward clinical utility of donor-derived cell-free DNA testing?
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children
Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: results of a Nephcure membranous nephropathy workshop
The prevention and management of chronic kidney disease among patients with metabolic syndrome
Somatic mutations acquired during life: state of the art and implications for the kidney
Melanocortin 5 receptor signaling protects against podocyte injury in proteinuric glomerulopathies
Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease
Repression of peroxisome proliferation-activated receptor γ coactivator-1α by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair
A kidney organoid-based readout to assess disease activity in primary and recurrent focal segmental glomerulosclerosis
A risk score to predict kidney survival in patients with autosomal recessive polycystic kidney disease at the age of two months
Guanidinylation compromises the anti-inflammatory and anti-oxidative properties of apolipoprotein A-I in chronic kidney disease progression
Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse model
Glomerular deposits of neuron-derived neurotrophic factor in a case of membranous nephropathy lacking syphilis signature
Lupus nephritis treat to target normalizing anti-dsDNA, C3, and C4 is a bridge too far
Clarifying criteria for complement-mediated TMA in patients without CFH antibodies or complement variants identified
Clarifying the interpretation of semaglutide’s impact in the FLOW study
PCSK6-associated membranous nephropathy in an adolescent with Sjögren disease
The Case | A patient with multiple myeloma, heart failure, and nonresolving acute kidney injury
Corrigendum to “Tolerogenic dendritic cells protect against acute kidney injury.� Kidney International 2023;104:492–507
